Grace Therapeutics, Inc. (GRCE): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-6, first reflected in a filing dated 2023-08-11. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Older than the company's other figures. The latest Shares Outstanding is for the year ended 2024-03-31, while the company's latest annual report covers the year ended 2026-03-31. Its later filings do not report this line under the concept TickerFacts maps.

9.40M
As of 2024-03-31
16.27M
As of 2026-06-30
44.29M2022-03-31: 44.29M2023-03-31: 7.44M2024-03-31: 9.40M9.40M
2022-03-31 Shares Outstanding (shares) 2024-03-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2024-03-319.40M+26.4%2024-06-21, Balance as of period end
2023-03-317.44Mn/c2024-06-21, Balance as of period end
2022-03-3144.29Mn/a2023-06-23, Balance as of period end